Abstract
Aim
The aim was to examine the clinical applicability of positron-emission tomography/computed tomography (PET/CT) for diagnosing local recurrence of colorectal cancer.
Methods
From August 2003 to August 2008, 256 patients with colorectal cancer underwent PET/CT scanning for staging or restaging. Local recurrence was detected in 22 patients (18 men, 4 women) postsurgically.
Results
Of the 22 patients, 21 (95.5%) underwent positive 2-[fluorine-18]-fluoro-2-deoxy-d-glucose uptake and were diagnosed with local recurrence by PET/CT; the results were negative in one case (4.5%). The sensitivity, specificity, positive predictive value, and negative predictive value for local recurrence were 95.5%, 100%, 100%, and 99.6%, respectively. CT/MRI scans yielded the following results: positive, 10 cases (45.5%); suspected positive, 11 cases (50.0%); negative, 1 case (4.5%). In the suspected positive cases, not only imaging but also colonoscopy and tumor markers among other techniques were used for definitive diagnosis.
Conclusion
PET/CT has high sensitivity and specificity for diagnosing local recurrence of colorectal cancer and would be useful especially in the case of locally recurrent colorectal cancer suspected to be positive by CT/MRI.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Watson AJ, Lolohea S, Robertson GM, Frizelle FA (2007) The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum 50:102–114
Schaefer O, Langer M (2007) Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 17:2044–2054
Herbertson RA, Scarsbrook AF, Lee ST, Tebbutt N, Scott AM (2009) Established, emerging and future roles of PET/CT in the management of colorectal cancer. Clin Radiol 64:225–237
Even-Sapir E, Parag Y, Lerman H, et al. (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815–822
Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA (1998) Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 227:319–323
Veit P, Kuhle C, Beyer T, et al. (2006) Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated pet/ct colonography: technical feasibility and first experiences in patients with colorectal cancer. Gut 55:68–73
Scott AM, Gunawardana DH, Kelley B, et al. (2008) PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective study. J Nucl Med 49:1451–1457
Vikram R, Iyer RB (2008) PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging 8(Suppl A):S46–S51
Potter KC, Husband JE, Houghton SL, Thomas K, Brown G (2009) Diagnostic accuracy of serial ct/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Dis Colon Rectum 52:253–259
Winton E, Heriot AG, Ng M, et al. (2009) The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer 100:693–700
Zhang C, Chen Y, Xue H, et al. (2009) Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer 124:167–173
Acknowledgment
We thank Dr. Y. Tada for his support in the suggestions.
Conflict of interest
None of the authors have any commercial or personal association that might pose a conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bamba, Y., Itabashi, M. & Kameoka, S. Management of local recurrence of colorectal cancer: the role of PET/CT. Abdom Imaging 36, 322–326 (2011). https://doi.org/10.1007/s00261-010-9639-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-010-9639-z